Yang Lü
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 44
- HER2/EGFR in Cancer Research 10
- Cancer-related Molecular Pathways 10
- Co-authors
- Zhen Fan (32 shared papers)John Mendelsohn (11 shared papers)Ke Liang (16 shared papers)Bolin Liu (8 shared papers)Xinqun Li (13 shared papers)Songbo Qiu (12 shared papers)Weidong Jin (5 shared papers)Gordon B. Mills (6 shared papers)
- Journals
- Cancer Letters (8 papers)Oncogene (7 papers)Journal of Cancer Research and Clinical Oncology (4 papers)Clinical Nuclear Medicine (31 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Yang Lü
166 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 125
- Oncology 1.7k
- Cancer Research 801
- Radiology, Nuclear Medicine and Imaging 600
- Pulmonary and Respiratory Medicine 797
- Molecular Biology 1.8k
Countries citing papers authored by Yang Lü
This map shows the geographic impact of Yang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Lü more than expected).
Fields of papers citing papers by Yang Lü
This network shows the impact of papers produced by Yang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Lü. The network helps show where Yang Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 390 | |
| 2 | 1994 | 244 | |
| 3 | Sensitization of breast cancer cells to radiation by trastuzumab. | 2003 | 207 |
| 4 | 2007 | 188 | |
| 5 | 2016 | 162 | |
| 6 | 2018 | 154 | |
| 7 | 2007 | 136 | |
| 8 | 2019 | 119 | |
| 9 | 2000 | 115 | |
| 10 | 2005 | 109 | |
| 11 | 2003 | 107 | |
| 12 | 2001 | 97 | |
| 13 | 2005 | 88 | |
| 14 | 2010 | 84 | |
| 15 | Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors. | 1997 | 84 |
| 16 | 2020 | 78 | |
| 17 | 2016 | 76 | |
| 18 | 2019 | 71 | |
| 19 | 2013 | 68 | |
| 20 | 2004 | 66 |
About Yang Lü
Yang Lü is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 173 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (19 papers), Prostate Cancer Treatment and Research (13 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers), HER2/EGFR in Cancer Research (10 papers), Cancer-related Molecular Pathways (10 papers), Adrenal and Paraganglionic Tumors (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (801 citations), Radiology, Nuclear Medicine and Imaging (600 citations), Pulmonary and Respiratory Medicine (797 citations) and Molecular Biology (1.8k citations). Yang Lü has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Zhen Fan, John Mendelsohn, Ke Liang, Bolin Liu, Xinqun Li, Songbo Qiu, Weidong Jin, Gordon B. Mills, Mathias Schmidt and Zhihong Fan. Their work appears in journals such as Cancer Letters, Oncogene, Journal of Cancer Research and Clinical Oncology, Clinical Nuclear Medicine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.